{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T02:19:12Z","timestamp":1789265952507,"version":"build-2803163510"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,12,27]]},"DOI":"10.1097\/tp.0b013e3182007b95","type":"journal-article","created":{"date-parts":[[2010,11,18]],"date-time":"2010-11-18T02:27:16Z","timestamp":1290047236000},"page":"1521-1527","source":"Crossref","is-referenced-by-count":114,"title":["An Integrated Safety Profile Analysis of Belatacept in Kidney Transplant Recipients"],"prefix":"10.1097","volume":"90","author":[{"given":"Josep","family":"Griny\u00f3","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Charpentier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Medina","family":"Pestana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Vanrenterghem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio","family":"Vincenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Reyes-Acevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Marie","family":"Apanovitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila","family":"Gujrathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamta","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolca","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian P.","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-45-20210129","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1600-6143.2005.00749.x","article-title":"Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties.","volume":"5","author":"Larsen","year":"2005","journal-title":"Am J Transplant"},{"key":"R2-45-20210129","doi-asserted-by":"crossref","first-page":"409","DOI":"10.5414\/CNP57409","article-title":"Hypertension in renal transplantation: Donor and recipient risk factors.","volume":"57","author":"Ducloux","year":"2002","journal-title":"Clin Nephrol"},{"key":"R3-45-20210129","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/ajhp\/61.6.565","article-title":"Drug-related dyslipidemia after renal transplantation.","volume":"61","author":"Mathis","year":"2004","journal-title":"Am J Health Syst Pharm"},{"key":"R4-45-20210129","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1056\/NEJMoa020009","article-title":"The natural history of chronic allograft nephropathy.","volume":"349","author":"Nankivell","year":"2003","journal-title":"N Engl J Med"},{"key":"R5-45-20210129","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1432-2277.2008.00640.x","article-title":"Immunosuppressive medications, clinical and metabolic parameters in new-onset diabetes mellitus after kidney transplantation.","volume":"21","author":"Roland","year":"2008","journal-title":"Transpl Int"},{"key":"R6-45-20210129","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1056\/NEJMoa050085","article-title":"Costimulation blockade with belatacept in renal transplantation.","volume":"353","author":"Vincenti","year":"2005","journal-title":"N Engl J Med"},{"key":"R7-45-20210129","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1600-6143.2009.03005.x","article-title":"A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study).","volume":"10","author":"Vincenti","year":"2010","journal-title":"Am J Transplant"},{"key":"R8-45-20210129","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1600-6143.2010.03016.x","article-title":"A phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (BENEFIT-EXT study).","volume":"10","author":"Durrbach","year":"2010","journal-title":"Am J Transplant"},{"key":"R9-45-20210129","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.2165\/11319260-000000000-00000","article-title":"Immunosuppressive drugs in kidney transplantation: Impact on patient survival, and incidence of cardiovascular disease, malignancy and infection.","volume":"69","author":"Marcen","year":"2009","journal-title":"Drugs"},{"key":"R10-45-20210129","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1681\/ASN.2009111109","article-title":"Five-year results of a phase II study with belatacept in renal transplantation.","volume":"21","author":"Vincenti","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"R11-45-20210129","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1097\/01.tp.0000179639.98338.39","article-title":"Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression.","volume":"80","author":"Caillard","year":"2005","journal-title":"Transplantation"},{"key":"R12-45-20210129","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/01.TP.0000165098.49658.F3","article-title":"Lymphoproliferative disease after renal transplantation in Australia and New Zealand.","volume":"80","author":"Faull","year":"2005","journal-title":"Transplantation"},{"key":"R13-45-20210129","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1046\/j.0007-1323.2001.01924.x","article-title":"Rising incidence of post-transplant lymphoproliferative disease in kidney transplant recipients.","volume":"88","author":"Libertiny","year":"2001","journal-title":"Br J Surg"},{"key":"R14-45-20210129","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/01.tp.0000188687.18972.a8","article-title":"Risk of lymphoma after renal transplantation varies with time: An analysis of the United States Renal Data System.","volume":"81","author":"Smith","year":"2006","journal-title":"Transplantation"},{"key":"R15-45-20210129","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1111\/j.1600-6143.2006.01540.x","article-title":"Post-transplant lymphoproliferative disorders occurring after renal transplantation in adults: Report of 230 cases from the French Registry.","volume":"6","author":"Caillard","year":"2006","journal-title":"Am J Transplant"},{"key":"R16-45-20210129","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1086\/514142","article-title":"Posttransplant lymphoproliferative disease in primary Epstein-Barr virus infection after liver transplantation: The role of cytomegalovirus disease.","volume":"176","author":"Manez","year":"1997","journal-title":"J Infect Dis"},{"key":"R17-45-20210129","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S1470-2045(07)70040-2","article-title":"Effect of cytomegalovirus prophylaxis with immunoglobulin or with antiviral drugs on post-transplant non-Hodgkin lymphoma: A multicentre retrospective analysis.","volume":"8","author":"Opelz","year":"2007","journal-title":"Lancet Oncol"},{"key":"R18-45-20210129","first-page":"495","article-title":"One year safety profile of belatacept in kidney transplant patients from the BENEFIT and BENEFIT-EXT studies.","volume":"9","author":"Larsen","year":"2009","journal-title":"Am J Transplant"},{"key":"R19-45-20210129","first-page":"41","article-title":"Pretransplant assessment of the risk for posttransplant lymphoproliferative disorder.","volume":"27","author":"Walker","year":"1995","journal-title":"Transplant Proc"},{"key":"R20-45-20210129","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.transproceed.2008.12.013","article-title":"Significant risk factors for occurrence of cancer after renal transplantation: A single center cohort study of 1265 cases.","volume":"41","author":"Bichari","year":"2009","journal-title":"Transplant Proc"},{"key":"R21-45-20210129","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/01.TP.0000055098.96022.F7","article-title":"Epstein-Barr virus seronegativity is a risk factor for late-onset posttransplant lymphoroliferative disorder in adult renal allograft recipients.","volume":"75","author":"Shahinian","year":"2003","journal-title":"Transplantation"},{"key":"R22-45-20210129","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/00007890-199501000-00016","article-title":"Central nervous system lymphomas in organ allograft recipients.","volume":"59","author":"Penn","year":"1995","journal-title":"Transplantation"},{"key":"R23-45-20210129","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1046\/j.1600-6143.2003.00325.x","article-title":"Lymphomas after solid organ transplantation: A collaborative transplant study report.","volume":"4","author":"Opelz","year":"2004","journal-title":"Am J Transplant"},{"key":"R24-45-20210129","first-page":"216","article-title":"Investigation of blood-brain barrier (BBB) permeability and immune-cell population of brain tissue in belatacept-treated monkeys.","volume":"10","author":"Freebern","year":"2010","journal-title":"Am J Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00007890-201012270-00045","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:37:01Z","timestamp":1786041421000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007890-201012270-00045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,27]]},"references-count":24,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0b013e3182007b95","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12,27]]}}}